Makoto Emori

2.0k citations
120 papers · 1.1k indexed · h-index 18

Makoto Emori

102 papers receiving 1.1k citations

Peers

Makoto Emori
Comparison fields: 5 of 123
  • Rheumatology 235
  • Oncology 388
  • Pulmonary and Respiratory Medicine 453
  • Pathology and Forensic Medicine 173
  • Oral Surgery 49
Replace Shintaro Sugita with:
Shintaro Sugita Japan
Xiaohua Qian United States
Takayuki Murase Japan
Yasuaki Aoki Japan
Jung Ryul Kim South Korea
Iva Brčić Austria
Howard A. Chansky United States
Céline Bazille France
Cathleen Raggio United States
Daniel A. Müller Switzerland
Makoto Emori relative to Shintaro Sugita Japan Shintaro Sugita's profile →
Citations per field
00.5×1.5×
Shintaro Sugita · 1×
Citations per year

Countries citing papers authored by Makoto Emori

Since Specialization
Citations

This map shows the geographic impact of Makoto Emori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Emori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Emori more than expected).

Fields of papers citing papers by Makoto Emori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Emori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Emori. The network helps show where Makoto Emori may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Makoto Emori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Makoto Emori Line = papers co-authored together Makoto Emori links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20231
4 20230
5 202310
6 20231
7 20229
8 20212
9 20212
10 20211
11 20208
12 20207
13 20205
14 20203
15 201910
16 20193
17 201917
18 20181
19 201012
20 20105

About Makoto Emori

Makoto Emori is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 120 papers that have together received 1.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (57 papers), Bone Tumor Diagnosis and Treatments (26 papers), Musculoskeletal pain and rehabilitation (15 papers), Cardiac tumors and thrombi (15 papers), Vascular Tumors and Angiosarcomas (13 papers), Spine and Intervertebral Disc Pathology (13 papers), Soft tissue tumor case studies (11 papers) and Musculoskeletal synovial abnormalities and treatments (8 papers). The work is most often cited by research in Rheumatology (235 citations), Oncology (388 citations) and Pulmonary and Respiratory Medicine (453 citations). Makoto Emori has collaborated with scholars based in Japan, Italy and United States. Frequent co-authors include Toshihiko Yamashita, Tadashi Hasegawa, Shintaro Sugita, Mitsunori Kaya, Kohichi Takada, Hiroko Asanuma, Terufumi Kubo, Tomoyuki Aoyama, Noriyuki Sato and Kazuyuki Murase. Their work appears in journals such as Diagnostic Pathology, Cancer Science, Asian Spine Journal, World Journal of Surgical Oncology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026